News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
504,225 Results
Type
Article (36930)
Company Profile (160)
Press Release (467135)
Section
Business (150968)
Career Advice (1543)
Deals (29034)
Drug Delivery (101)
Drug Development (70942)
Employer Resources (125)
FDA (11904)
Job Trends (11387)
News (270115)
Policy (29645)
Tag
Academia (1948)
Alliances (46499)
Alzheimer's disease (1096)
Approvals (11864)
Artificial intelligence (120)
Bankruptcy (266)
Best Places to Work (8865)
Breast cancer (145)
Cancer (1122)
Cardiovascular disease (85)
Career advice (1295)
Cell therapy (228)
Clinical research (56823)
Collaboration (445)
Compensation (226)
COVID-19 (2497)
C-suite (86)
Data (1106)
Diabetes (154)
Diagnostics (3944)
Drug pricing (93)
Earnings (54674)
Employer resources (113)
Events (67856)
Executive appointments (292)
FDA (12468)
Funding (316)
Gene therapy (171)
GLP-1 (638)
Government (4245)
Healthcare (12595)
Infectious disease (2590)
Inflammatory bowel disease (90)
Interviews (266)
IPO (12401)
Job creations (2908)
Job search strategy (1125)
Layoffs (329)
Legal (7790)
Lung cancer (164)
Lymphoma (84)
Manufacturing (197)
Medical device (6476)
Medtech (6479)
Mergers & acquisitions (16792)
Metabolic disorders (447)
Neuroscience (1368)
NextGen Class of 2024 (4295)
Non-profit (3003)
Northern California (1244)
Obesity (264)
Opinion (201)
Parkinson's disease (83)
Patents (108)
People (40681)
Phase I (16974)
Phase II (24888)
Phase III (19608)
Pipeline (436)
Postmarket research (2241)
Preclinical (7077)
Radiopharmaceuticals (225)
Rare diseases (218)
Real estate (4086)
Regulatory (18986)
Research institute (1817)
Resumes & cover letters (226)
Southern California (1074)
Startups (2659)
United States (10768)
Vaccines (609)
Weight loss (213)
Date
Today (101)
Last 7 days (462)
Last 30 days (1833)
Last 365 days (26868)
2024 (26756)
2023 (30164)
2022 (39764)
2021 (42682)
2020 (40785)
2019 (33743)
2018 (25785)
2017 (25546)
2016 (24373)
2015 (28200)
2014 (22328)
2013 (18495)
2012 (19699)
2011 (20398)
2010 (18736)
Location
Africa (690)
Arizona (98)
Asia (33673)
Australia (5349)
California (2748)
Canada (1138)
China (257)
Colorado (125)
Connecticut (133)
Europe (74444)
Florida (394)
Georgia (87)
Illinois (266)
Indiana (165)
Maryland (525)
Massachusetts (2095)
Michigan (95)
Minnesota (127)
New Jersey (891)
New York (816)
North Carolina (531)
Northern California (1244)
Ohio (99)
Pennsylvania (643)
South America (996)
Southern California (1074)
Texas (374)
Washington State (262)
504,225 Results for "aop orphan pharmaceuticals ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Hematology/Oncology: AOP Health’s Expanding Clinical Research Program Delivers New Results
AOP Orphan Pharmaceuticals GmbH continues a successful clinical research program in hematology/oncology with two abstracts accepted for presentation at the European Hematology Association 2024 hybrid congress in Madrid, Spain.
June 10, 2024
·
6 min read
Press Releases
U.S. FDA Approves AOP Health’s RapiblykTM (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting
November 27, 2024
·
8 min read
Press Releases
Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to Five
December 19, 2024
·
11 min read
Press Releases
Cancer Therapy: AOP Health Investigates a New Approach Targeting Cancer Stem Cells
October 1, 2024
·
3 min read
Press Releases
ImmuneSensor Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designations from the U.S. FDA for cGAS Inhibitor Drug Candidate, IMSB301, for the Treatment of Aicardi Goutières Syndrome (AGS)
November 20, 2024
·
5 min read
Blood Cancer: AOP Health Announces New Findings in Patients With Polycythemia Vera Published in Medical Journal Leukemia
AOP Orphan Pharmaceuticals GmbH announced the publication of final results on the recently developed interferon therapy, ropeginterferon alfa-2b, in patients with polycythemia vera in the prestigious journal Leukemia.
September 19, 2023
·
4 min read
Press Releases
Agios Announces FDA Orphan Drug Designation Granted to Tebapivat (AG-946) for Treatment of Myelodysplastic Syndromes (MDS)
September 11, 2024
·
5 min read
Biotech Beach
Blood Cancer: AOP Health Announces New Findings in Patients With Polycythemia Vera to Be Presented at the American Society of Hematology (ASH) 65th Annual Meeting
AOP Orphan Pharmaceuticals GmbH announced the results of an analysis assessing the impact of an individually optimized dosing regimen of ropeginterferon alfa-2b on treatment response in patients with low-risk polycythaemia vera 1 These new data show that some low-risk PV patients require and can tolerate high ropeginterferon alfa-2b doses, and that the optimal dose varies substantially between patients.
December 7, 2023
·
3 min read
Press Releases
European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios’ Mitapivat in Sickle Cell Disease
December 19, 2024
·
8 min read
Pharm Country
Rocket Pharmaceuticals Receives Orphan Medicinal Product Designation from the European Commission for RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy
Rocket Pharmaceuticals, Inc. today announced that the European Commission (EC), based on a positive opinion issued by the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA), has granted orphan medicinal product designation for RP-A601.
May 29, 2024
·
7 min read
1 of 50,423
Next
